Woolfson Eye Institute
Clinical trials sponsored by Woolfson Eye Institute, explained in plain language.
-
Shorter light therapy may be just as good for treating bulging corneas
Disease control Recruiting nowThis phase 3 trial tests whether a shorter 18-minute ultraviolet (UVA) light exposure works as well as the standard 24-minute exposure during corneal crosslinking for keratoconus and similar conditions. The treatment uses riboflavin (vitamin B2) eye drops followed by UVA light to…
Phase: PHASE3 • Sponsor: Woolfson Eye Institute • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC
-
New hope for down syndrome vision loss: light therapy trial launches
Disease control Recruiting nowThis Phase 3 trial tests a treatment called corneal crosslinking (CXL) for people with Down syndrome who have keratoconus, a condition where the cornea thins and bulges, blurring vision. The procedure uses vitamin B2 eye drops and ultraviolet light to strengthen the cornea. Resea…
Phase: PHASE3 • Sponsor: Woolfson Eye Institute • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC